arrow
Á

Ángel Aledo-Serrano

vithas madrid university hospitals
H指数:21
被引数:2,198

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness and tolerability of fenfluramine in pediatric and adult patients with developmental and epileptic encephalopathies: A multicenter, retrospective, real-world clinical-practice study

芬氟拉明在发育性和癫痫性脑病患儿及成人患者中的有效性与耐受性:一项多中心、回顾性、真实世界临床实践研究

2026-07-300
OAAI
Crisis epilépticas en niños con síndrome de Dravet en condiciones de calor extremo: estudio cualitativo de la perspectiva de los progenitores

德劳特综合征患儿在极端高温条件下的癫痫发作:父母视角的定性研究

2026-02-010
OAAI
Real-world use of cenobamate in pediatric focal epilepsies and developmental epileptic encephalopathies: A multicenter retrospective series

cenobamate在儿科局灶性癫痫和发育性癫痫性脑病中的真实世界应用:一项多中心回顾性系列研究

2025-07-300
PRE
Current and Future Treatment Strategies in Developmental and/or Epileptic Encephalopathy With Spike-Wave Activation in Sleep (DEE-SWAS): A Time for Precision Medicine?

发育性/癫痫性脑病伴睡眠棘慢波激活(DEE-SWAS)的当前和未来治疗策略:精准医学的时代?

2025-06-210
PRE
The genetic and phenotypic spectrum of GABRB1-related disorders
Brain
IF11.7
2025-06-050
OA
Fenfluramine: an effective treatment for developmental epileptic encephalopathies beyond Dravet and Lennox-Gastaut Syndromes

芬氟拉明:一种有效的治疗Dravet和Lennox-Gastaut综合征以外发育性癫痫性脑病的方法

2025-05-140
PRE
Cenobamate as add-on treatment for SCN8A developmental and epileptic encephalopathy

Cenobamate作为SCN8A发育性和癫痫性脑病的附加治疗

2025-01-150
PRE
Real-world experience of diagnosis, disability, and daily management in parents of children with different genetic developmental and epileptic encephalopathies: a qualitative study

不同遗传发育性和癫痫性脑病患儿父母的诊断,残疾和日常管理的真实经验: 定性研究

2024-12-280
OAAI
Incidence and predictors of posttraumatic epilepsy and cognitive impairment in patients with traumatic brain injury: A retrospective cohort study in Malaysia

创伤性脑损伤患者外伤性癫痫和认知障碍的发生率和预测因素: 马来西亚的一项回顾性队列研究

2024-05-162
OAAI
Developmental epileptic encephalopathy in DLG4-related synaptopathy

DLG4-related突触病的发展性癫痫脑病

2024-02-291
OA
Adult Phenotype of SYNGAP1-DEE
2023-12-013
OAAI